دورية أكاديمية

Long-Term Follow-Up of Single-Fiber Multiple Low-Intensity Energy Laser Ablation Technique of Benign Thyroid Nodules

التفاصيل البيبلوغرافية
العنوان: Long-Term Follow-Up of Single-Fiber Multiple Low-Intensity Energy Laser Ablation Technique of Benign Thyroid Nodules
المؤلفون: Squarcia, Mattia, Mora, Mireia, Aranda, Gloria, Carrero Cardenal, Enrique J. (Jesús), Martínez, Daniel, Jerez, Ramona, Valero, Ricard, Berenguer, Joan, Halperin, Irene, Hanzu, Felicia A.
المصدر: Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)
بيانات النشر: Frontiers Media
سنة النشر: 2021
المجموعة: Dipòsit Digital de la Universitat de Barcelona
مصطلحات موضوعية: Serveis de cures de llarga durada, Malalties de la tiroide, Ablació amb làser, Long-term care facilities, Thyroid diseases, Laser ablation
الوصف: Aim: The short-term and long-term efficacy of different thermal percutaneous ablation techniques remains a topical issue. Our group implemented percutaneous laser ablation (LA), a moving-shot technique to increase efficiency and reduce costs and variability of LA by applying multiple lower-intensity energy illuminations (MLIEI) covering the nodular volume (V) through changes in position of a single laser fiber within the thyroid nodule. The aim of the present study was to evaluate the efficacy of the single-fiber LA-MLIEI during a 5-year follow-up and to identify possible predictors of the final outcome. Methods: Prospective study: Thirty outpatients (23 women and seven men) with benign symptomatic thyroid nodules were assigned to single-fiber LA-MLIEI, between 2012 and 2015. A single LA session was performed under real-time ultrasound (US) guidance using a 1,064-nm continuous-wave laser at 3 W. A 400-µm optical fiber was inserted through a 21-gauge needle, and 3-10 illuminations were performed per nodule, administering between 400 and 850 J/illumination. The total administered energy was calculated on the initial V of the nodule and the estimated ablation area. US evaluation was performed after LA-MLIEI at 1 week and 1, 3, 6, and 12 months and after that annually up to 5 years. Clinical symptoms, laboratory thyroid function during follow-up, and acute and chronic complications of treatment were registered.
نوع الوثيقة: article in journal/newspaper
وصف الملف: 9 p.; application/pdf
اللغة: English
تدمد: 2234-943X
العلاقة: Reproducció del document publicat a: https://doi.org/10.3389/fonc.2021.584265Test; Frontiers In Oncology, 2021, vol. 11, num. 584265, p. 1-9; https://doi.org/10.3389/fonc.2021.584265Test; http://hdl.handle.net/2445/194794Test; 718114
الإتاحة: https://doi.org/10.3389/fonc.2021.584265Test
http://hdl.handle.net/2445/194794Test
حقوق: cc-by (c) Squarcia, Mattia et al., 2021 ; https://creativecommons.org/licenses/by/4.0Test/ ; info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.AFC14834
قاعدة البيانات: BASE